Pulsed Laser Acupuncture in the Treatment of Pain and Heart Rate Variability in Fibromyalgia Patients: A Pilot Randomized Clinical Trial.

Researchers conducted a small study to test whether laser acupuncture using pulsed frequencies could help women with fibromyalgia manage their pain. Fibromyalgia is a chronic condition that causes widespread pain throughout the body, and traditional treatments don't work for everyone. This study looked at a newer approach using laser acupuncture instead of needles.

The study involved 20 women between ages 40 and 80 with fibromyalgia. Half received pulsed laser acupuncture treatments twice weekly for three weeks, while the other half served as controls. The researchers measured pain levels using several different scales and also looked at heart rate variability, which reflects how the nervous system controls heart rhythm.

The results were encouraging for pain relief. Women who received the laser acupuncture reported significant improvements in their pain levels across all three measurement scales used in the study. The treatment protocol was individualized, meaning practitioners selected specific acupuncture points based on each woman's unique symptoms and presentation.

Interestingly, while pain decreased, the study found no changes in heart rate variability. This suggests that the laser acupuncture helped with pain symptoms directly, but didn't appear to affect the autonomic nervous system functioning in measurable ways during this short study period.

Because this was a small pilot study with only 20 participants and a brief treatment period, more research with larger groups is needed to confirm these findings. However, the results suggest that pulsed laser acupuncture may offer a non-invasive option for fibromyalgia patients seeking pain relief. If you're interested in laser acupuncture for fibromyalgia, consult with a licensed acupuncturist trained in laser therapy techniques.

This pilot RCT evaluated pulsed laser acupuncture (LA) for fibromyalgia pain and autonomic modulation in 20 women aged 40-80, randomized to experimental (n=10) or control (n=10) groups. The experimental group received individualized pulsed LA protocols twice weekly for three weeks. Primary outcomes included pain numerical scale (PNS), generalized pain index (GPI), and symptom severity scale (SSS); secondary outcomes measured heart rate variability (HRV) parameters.

Results demonstrated statistically significant reductions in pain intensity across all pain measures: PNS (P=0.00), GPI (P=0.00), and SSS (P=0.00). However, no significant changes were observed in any HRV variables (P>0.05), suggesting the intervention did not affect cardiac autonomic modulation during this treatment period.

Clinical takeaway: Individualized pulsed LA protocols show promise for reducing subjective pain measures in fibromyalgia patients over short-term treatment, though autonomic effects remain unclear. Larger trials with extended follow-up periods are needed to establish optimal protocols and long-term efficacy.